TATVA

Tatva Chintan Pharma Chem Share PriceTatva Chintan Pharma Chem

₹1,564.95
57.2 (3.79%)
  • Advice
  • Hold
As on 02 December, 2023 | 00:31 BSE: 543321 NSE: TATVAISIN: INE0GK401011

Tatva Chintan Pharma Chem Performance

Day Range

  • Low 1,516.05
  • High 1,586.00
₹ 1,564.95

52 Week Range

  • Low 1,399.90
  • High 2,323.00
₹ 1,564.95
  • Open Price1,520.00
  • Previous Close1,507.75
  • Volume65475

Start SIP in Tatva Chintan Pharma Chem

Start SIP

Tatva Chintan Pharma Chem Share Price

  • Over 1 Month 7.95%
  • Over 3 Month -9.13%
  • Over 6 Month -5.4%
  • Over 1 Year -30.07%

Tatva Chintan Pharma Chem Key Statistics

P/E Ratio 79.8
PEG Ratio -4
Market Cap Cr 3,661
Price to Book Ratio 7.1
EPS 18.8
Dividend 0.1
Relative Strength Index 63.63
Money Flow Index 66.13
MACD Signal -11.7
Average True Range 42.08

Tatva Chintan Pharma Chem Investment Rating

  • Master Rating:
  • Tatva Chintan Pharma Chem has an operating revenue of Rs. 456.15 Cr. on a trailing 12-month basis. An annual revenue de-growth of -3% needs improvement, Pre-tax margin of 11% is healthy, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 6 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 70 indicates it belongs to a poor industry group of Chemicals-Basic and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Tatva Chintan Pharma Chem Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 931061191148486102
Operating Expenses Qtr Cr 728610497757380
Operating Profit Qtr Cr 2120151791322
Depreciation Qtr Cr 7632222
Interest Qtr Cr 3332111
Tax Qtr Cr 43-93231
Net Profit Qtr Cr 8816115919
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 409438
Operating Expenses Annual Cr 348322
Operating Profit Annual in Cr 55106
Depreciation Cr 108
Interest Annual Cr 85
Tax Annual Cr -27
Net Profit Annual Cr 4096
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 2420
Cash from Investing Activity Annual Cr -101-197
Cash from Financing Annual Activity Cr 38235
Net Cash Flow Annual Cr -4058
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 505469
Fixed Assets Annual Cr 427211
Total Non Current Assets Annual Cr 443223
Total Current Assets Annual Cr 311429
Total Assets Annual Cr 755652
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 228212
ROE Annual % 820
ROCE Annual % 1022
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1527
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 97114125121908899
Operating Expenses Qtr Cr 7693108103797377
Operating Profit Qtr Cr 20211618111522
Depreciation Qtr Cr 7632222
Interest Qtr Cr 3333111
Tax Qtr Cr 34-93241
Net Profit Qtr Cr 810171271018
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 429443
Operating Expenses Annual Cr 363325
Operating Profit Annual in Cr 61108
Depreciation Cr 108
Interest Annual Cr 85
Tax Annual Cr -18
Net Profit Annual Cr 4596
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 2820
Cash from Investing Activity Annual Cr -101-197
Cash from Financing Annual Activity Cr 38235
Net Cash Flow Annual Cr -3659
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 515473
Fixed Assets Annual Cr 427211
Total Non Current Assets Annual Cr 443222
Total Current Assets Annual Cr 314436
Total Assets Annual Cr 756658
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 232213
ROE Annual % 920
ROCE Annual % 1122
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1627

Tatva Chintan Pharma Chem Technicals

EMA & SMA

Current Price
₹1,564.95
57.2 (3.79%)
pointer
  • Bullish Moving Average
  • ___
  • 11
  • Bearish Moving Average
  • ___
  • 5
  • 20 Day
  • ₹1,499.30
  • 50 Day
  • ₹1,532.01
  • 100 Day
  • ₹1,594.00
  • 200 Day
  • ₹1,715.79
  • 20 Day
  • ₹1,492.34
  • 50 Day
  • ₹1,525.53
  • 100 Day
  • ₹1,606.91
  • 200 Day
  • ₹1,680.43

Tatva Chintan Pharma Chem Resistance and Support

PIVOT
₹1,555.67
Resistance
First Resistance 1,595.28
Second Resistance 1,625.62
Third Resistance 1,665.23
RSI 63.63
MFI 66.13
MACD Single Line -11.70
MACD -2.96
Support
First Resistance 1,525.33
Second Resistance 1,485.72
Third Resistance 1,455.38

Tatva Chintan Pharma Chem Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 76,451 4,209,392 55.06
Week 32,606 1,921,116 58.92
1 Month 19,234 1,161,148 60.37
6 Month 36,006 2,401,572 66.7

Tatva Chintan Pharma Chem Result Highlights

Tatva Chintan Pharma Chem Synopsis

NSE-Chemicals-Basic

Tatva Chintan Pharm is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 403.04 Cr. and Equity Capital is Rs. 22.17 Cr. for the Year ended 31/03/2023. Tatva Chintan Pharma Chem Ltd. is a Public Limited Listed company incorporated on 12/06/1996 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ1996PLC029894 and registration number is 029894.
Market Cap 3,668
Sales 432
Shares in Float 0.65
No of funds 39
Yield 0.14
Book Value 6.62
U/D Vol ratio 0.4
LTDebt / Equity 1
Alpha -0.19
Beta 0.74

Tatva Chintan Pharma Chem

Owner NameSep-23Aug-23Jun-23Mar-23
Promoters 72.02%75.02%79.17%79.17%
Mutual Funds 13.54%13.57%10.76%10.98%
Insurance Companies 0.11%0.11%0.12%0.53%
Foreign Portfolio Investors 4.4%4.13%3.19%3.54%
Individual Investors 8.72%6.23%5.91%5.09%
Others 1.21%0.94%0.85%0.69%

Tatva Chintan Pharma Chem Management

Name Designation
Mr. Chintan Nitinkumar Shah Chairman & Managing Director
Mr. Ajaykumar Mansukhlal Patel Whole Time Director
Mr. Shekhar Rasiklal Somani Whole Time Director
Dr. Manher Chimanlal Desai Independent Director
Mr. Subhash Ambubhai Patel Independent Director
Dr. Avani Rajesh Umatt Independent Director

Tatva Chintan Pharma Chem Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Tatva Chintan Pharma Chem Corporate Action

Date Purpose Remarks
2023-11-02 Quarterly Results
2023-08-04 Quarterly Results
2023-07-11 Preferential issue of shares
2023-05-05 Audited Results & Final Dividend
2023-01-24 Quarterly Results
Date Purpose Remarks
2022-09-09 FINAL Rs.2.00 per share(20%)Final Dividend

Tatva Chintan Pharma Chem MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 37,319
SBI Magnum Midcap Fund Regular Growth 13,202
Nippon India ELSS Tax Saver Fund Growth 12,323
Mirae Asset Hybrid-Equity Fund -Regular Plan-Growth 7,611
ICICI Prudential Smallcap Fund Growth 6,003

Tatva Chintan Pharma Chem FAQs

What is Share Price of Tatva Chintan Pharma Chem ?

Tatva Chintan Pharma Chem share price is ₹1,564 As on 02 December, 2023 | 00:17

What is the Market Cap of Tatva Chintan Pharma Chem ?

The Market Cap of Tatva Chintan Pharma Chem is ₹3660.7 Cr As on 02 December, 2023 | 00:17

What is the P/E ratio of Tatva Chintan Pharma Chem ?

The P/E ratio of Tatva Chintan Pharma Chem is 79.8 As on 02 December, 2023 | 00:17

What is the PB ratio of Tatva Chintan Pharma Chem ?

The PB ratio of Tatva Chintan Pharma Chem is 7.1 As on 02 December, 2023 | 00:17

Q2FY23